General Information of the Compound
Compound ID
CP0574253
Compound Name
1-benzhydryl-4-[4-(5-phenyltetrazol-1-yl)butyl]piperazine
    Show/Hide
Structure
Formula
C28H32N6
Molecular Weight
452.606
Canonical SMILES
C(CCn1nnnc1-c1ccccc1)CN1CCN(CC1)C(c1ccccc1)c1ccccc1
    Show/Hide
InChI
InChI=1S/C28H32N6/c1-4-12-24(13-5-1)27(25-14-6-2-7-15-25)33-22-20-32(21-23-33)18-10-11-19-34-28(29-30-31-34)26-16-8-3-9-17-26/h1-9,12-17,27H,10-11,18-23H2
    Show/Hide
InChIKey
KQWXBVOQMYQBBP-UHFFFAOYSA-N
Physicochemical Property
logP
4.5275
Rotatable Bonds
9
Heavy Atom Count
34
Polar Areas
50.08
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
6
Complexity
34

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 168287090
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01449, P2X purinoceptor 7
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000186 RPMI-8226 Homo sapiens (Human)  1
1
IC50 = 3200 nM
   TI
   LI
   LO
   TS